Log In
Print this Print this

GP96-Ig HIV vaccine

  Manage Alerts
Collapse Summary General Information
Company Heat Biologics Inc.
DescriptionVaccine that uses ImPACT technology to induce cells to continually secrete heat shock 90 kDa protein beta 1 (Hsp90B1; GP96) to ultimately activate dendritic cells and promote an immune response
Molecular Target Heat shock 90 kDa protein beta 1 (Hsp90B1) (GP96) (GRP94)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today